Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

Cited In for PubMed (Select 16099791)

1.

The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop.

Pagliari D, Urgesi R, Frosali S, Riccioni ME, Newton EE, Landolfi R, Pandolfi F, Cianci R.

J Immunol Res. 2015;2015:123653. doi: 10.1155/2015/123653. Epub 2015 May 18. Review.

2.

Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease.

Chehoud C, Albenberg LG, Judge C, Hoffmann C, Grunberg S, Bittinger K, Baldassano RN, Lewis JD, Bushman FD, Wu GD.

Inflamm Bowel Dis. 2015 Aug;21(8):1948-56. doi: 10.1097/MIB.0000000000000454.

PMID:
26083617
3.

Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives.

Tontini GE, Vecchi M, Pastorelli L, Neurath MF, Neumann H.

World J Gastroenterol. 2015 Jan 7;21(1):21-46. doi: 10.3748/wjg.v21.i1.21.

4.

Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease.

Wang ZK, Yang YS, Chen Y, Yuan J, Sun G, Peng LH.

World J Gastroenterol. 2014 Oct 28;20(40):14805-20. doi: 10.3748/wjg.v20.i40.14805.

5.

Serum anti-glycan antibodies in paediatric-onset Crohn's disease: association with disease phenotype and diagnostic accuracy.

Sładek M, Wasilewska A, Swiat A, Cmiel A.

Prz Gastroenterol. 2014;9(4):232-41. doi: 10.5114/pg.2014.45106. Epub 2014 Sep 16.

6.

Novel clinical and diagnostic aspects of antineutrophil cytoplasmic antibodies.

Schulte-Pelkum J, Radice A, Norman GL, Lόpez Hoyos M, Lakos G, Buchner C, Musset L, Miyara M, Stinton L, Mahler M.

J Immunol Res. 2014;2014:185416. doi: 10.1155/2014/185416. Epub 2014 Jun 5. Review.

7.

Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature.

Kelkka T, Kienhöfer D, Hoffmann M, Linja M, Wing K, Sareila O, Hultqvist M, Laajala E, Chen Z, Vasconcelos J, Neves E, Guedes M, Marques L, Krönke G, Helminen M, Kainulainen L, Olofsson P, Jalkanen S, Lahesmaa R, Souto-Carneiro MM, Holmdahl R.

Antioxid Redox Signal. 2014 Dec 1;21(16):2231-45. doi: 10.1089/ars.2013.5828. Epub 2014 Jul 29.

PMID:
24787605
8.

Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE.

Deane KD, El-Gabalawy H.

Nat Rev Rheumatol. 2014 Apr;10(4):212-28. doi: 10.1038/nrrheum.2014.6. Epub 2014 Feb 11. Review.

9.

Targeting tissular immune response improves diagnostic performance of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease.

Bertin D, Grimaud JC, Lesavre N, Benelmouloud C, Desjeux A, Garcia S, Desplat-Jégo S.

PLoS One. 2013 Nov 26;8(11):e80433. doi: 10.1371/journal.pone.0080433. eCollection 2013.

10.

Inflammatory bowel disease serology in Asia and the West.

Prideaux L, Kamm MA, De Cruz P, van Langenberg DR, Ng SC, Dotan I.

World J Gastroenterol. 2013 Oct 7;19(37):6207-13. doi: 10.3748/wjg.v19.i37.6207.

11.

Immunohistochemical analysis of retinoblastoma and β-catenin as an assistant tool in the differential diagnosis between Crohn's disease and ulcerative colitis.

Soletti RC, Rodrigues NA, Biasoli D, Luiz RR, de Souza HS, Borges HL.

PLoS One. 2013 Aug 14;8(8):e70786. doi: 10.1371/journal.pone.0070786. eCollection 2013.

12.

Gastrointestinal-associated autoantibodies in different autoimmune diseases.

Shor DB, Orbach H, Boaz M, Altman A, Anaya JM, Bizzaro N, Tincani A, Cervera R, Espinosa G, Stojanovich L, Rozman B, Bombardieri S, Vita SD, Damoiseaux J, Villalta D, Tonutti E, Tozzoli R, Barzilai O, Ram M, Blank M, Agmon-Levin N, Shoenfeld Y.

Am J Clin Exp Immunol. 2012 May 25;1(1):49-55. Print 2012.

13.

Serological markers of inflammatory bowel disease.

Kuna AT.

Biochem Med (Zagreb). 2013;23(1):28-42. Review.

14.

Immunologic and genetic markers in patients with idiopathic ocular inflammation and a family history of inflammatory bowel disease.

Abbasian J, Martin TM, Patel S, Tessler HH, Goldstein DA.

Am J Ophthalmol. 2012 Jul;154(1):72-7. doi: 10.1016/j.ajo.2012.01.016. Epub 2012 Mar 30.

15.

Increased levels of anti-glycan antibodies in patients with cystic fibrosis.

Hirche TO, Stein J, Hirche H, Hausmann J, Wagner TO, Behrens F, Schröder O.

Eur J Med Res. 2011 Sep 12;16(9):385-90.

16.

Current and future role of biomarkers in Crohn's disease risk assessment and treatment.

Tamboli CP, Doman DB, Patel A.

Clin Exp Gastroenterol. 2011;4:127-40. doi: 10.2147/CEG.S18187. Epub 2011 Jun 2.

17.

Characterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysis.

Rieder F, Lopez R, Franke A, Wolf A, Schleder S, Dirmeier A, Schirbel A, Rosenstiel P, Dotan N, Schreiber S, Rogler G, Klebl F.

PLoS One. 2011 May 6;6(5):e18172. doi: 10.1371/journal.pone.0018172.

18.

The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Tlaskalová-Hogenová H, Stěpánková R, Kozáková H, Hudcovic T, Vannucci L, Tučková L, Rossmann P, Hrnčíř T, Kverka M, Zákostelská Z, Klimešová K, Přibylová J, Bártová J, Sanchez D, Fundová P, Borovská D, Srůtková D, Zídek Z, Schwarzer M, Drastich P, Funda DP.

Cell Mol Immunol. 2011 Mar;8(2):110-20. doi: 10.1038/cmi.2010.67. Epub 2011 Jan 31. Review.

19.

Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.

Kamat A, Ancuta P, Blumberg RS, Gabuzda D.

PLoS One. 2010 Nov 15;5(11):e15533. doi: 10.1371/journal.pone.0015533.

20.

Serologic investigations in children with inflammatory bowel disease and food allergy.

Grzybowska-Chlebowczyk U, Woś H, Sieroń AL, Wiecek S, Auguściak-Duma A, Koryciak-Komarska H, Kasznia-Kocot J.

Mediators Inflamm. 2009;2009:512695. doi: 10.1155/2009/512695. Epub 2009 Dec 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk